Back to search

Article

Epigenetic silencing of MAFG is a potential prognosis biomarker in lung adenocarcinomas

2026-05-29

Abstract excerpt

<h4>ABSTRACT</h4> Non-small cell lung cancer (NSCLC) remains one of the leading causes of cancer-related mortality, partly because it is often diagnosed at advanced stages and frequently develops resistance to platinum-based chemotherapy. We previously showed that MAFG becomes derepressed following miR-7 hypermethylation, promoting platinum resistance in NSCLC and ovarian cancer cell lines. Although MAFG is a wel...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
19e9956c-3b70-56c0-97a4-c207ca6d87f7
DOI
10.64898/2026.05.26.724922
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Epigenetic silencing of MAFG is a potential prognosis biomarker in lung adenocarcinomasDOI 10.64898/2026.05.26.724922
Select a neighboring publication to make it the new centre.